our data establish that prostate cancer cell response to prototypic mitogens is representative of that of nonneoplastic cells and imply that c3 cell insensitivity to prostate cancer cell or prototypic mitogens represents defects in cellular response mechanisms .
C0376358
prostate cancer
C0334227
cell